4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-009353
CHIEF COMMERCIAL OFFICER gave up 563 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 360 shares (grant or award)
- CHIEF COMMERCIAL OFFICER acquired 995 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-07-15 | Grant or award | +360 | $9.56 | $3,442 | 7,732 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-09-02 | Option exercise | +995 | 8,727 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-09-02 | Shares withheld for taxes | −563 | $11.44 | $6,441 | 8,164 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-09-01 | Grant or award · Share Option | +59,460 | 59,460 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-09-01 | Grant or award · Restricted Share Unit | +9,908 | 9,908 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-09-02 | Option exercise · Restricted Share Unit | −995 | 2,982 | D | ||
Loading xslF345X03/form4-09062022_010900.xml…